Fennec Pharmaceuticals Announces European Commission Marketing Authorization for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology PatientsGlobeNewsWire • 06/06/23
Adherex Technologies Inc. (FENC) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/11/23
Fennec Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/23
Fennec Pharmaceuticals to Report First Quarter 2023 Financial Results on May 11, 2023GlobeNewsWire • 05/08/23
Fennec Pharmaceuticals: Undervalued, Near-Cash-Flow-Positive, Possible Buyout CandidateSeeking Alpha • 04/26/23
Fennec Pharmaceuticals Receives Positive CHMP Opinion for Pedmarqsi™ (sodium thiosulfate) to Reduce the Risk of Hearing Loss in Pediatric Oncology PatientsGlobeNewsWire • 03/31/23
Adherex Technologies Inc. (FENC) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/30/23
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2022 Financial ResultsGlobeNewsWire • 03/30/23
Why Earnings Season Could Be Great for Adherex Technologies (FENC)Zacks Investment Research • 02/23/23
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDAGlobeNewsWire • 01/31/23
Fennec Pharmaceuticals Announces Updated NCCN Clinical Practice Guidelines Recommend PEDMARK® (sodium thiosulfate injection) to Reduce the Risk of Cisplatin-Induced Hearing Loss in Pediatric PatientsGlobeNewsWire • 01/25/23
Fennec Pharmaceuticals Announces Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/11/22
Fennec: Pedmark Approval Can Help Minimize Chemo-Induced Hearing Loss In Pediatric Cancer PatientsSeeking Alpha • 10/24/22
Fennec Pharmaceuticals Announces Commercial Availability of PEDMARK® (sodium thiosulfate injection) in the United StatesGlobeNewsWire • 10/17/22
Fennec Pharmaceuticals Announces Second Closing of $20 Million Investment from PetrichorGlobeNewsWire • 09/26/22
Fennec Pharmaceuticals Announces FDA Approval of PEDMARK® (Sodium Thiosulfate Injection)GlobeNewsWire • 09/21/22
Fennec Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/12/22